3H-spiperone binding to lymphocytes fails in the differential diagnosis of de novo Parkinson syndromes

[1]  W. Oertel,et al.  Apomorphine test for dopaminergic responsiveness in patients with previously untreated Parkinson's disease. , 1992, Archives of neurology.

[2]  B. Bondy,et al.  Spiperone Binding in Lymphocytes: Part of a Dopamine Uptake System? , 1992, Annals of the New York Academy of Sciences.

[3]  J. Kornhuber,et al.  3H-spiroperidol binding to human peripheral mononuclear cells: Methodological aspects , 1992, Biological Psychiatry.

[4]  A. Lees,et al.  Challenge tests to predict the dopaminergic response in untreated Parkinson's disease , 1991, Neurology.

[5]  A. Lees,et al.  Apomorphine test to predict dopaminergic responsiveness in parkinsonian syndromes , 1990, The Lancet.

[6]  B. Bondy,et al.  [3H] Spiperone Binding to Lymphocytes in Psychiatric Disorders , 1990 .

[7]  Ward Cd,et al.  Research diagnostic criteria for Parkinson's disease. , 1990 .

[8]  B. Bondy,et al.  Methodology of 3H-spiperone binding to lymphocytes. , 1990, Journal of psychiatric research.

[9]  W. Poewe,et al.  APOMORPHINE TEST FOR DOPAMINERGIC RESPONSIVENESS , 1989, The Lancet.

[10]  W. Gibb,et al.  THE SIGNIFICANCE OF THE LEWY BODY IN THE DIAGNOSIS OF IDIOPATHIC PARKINSON'S DISEASE , 1989, Neuropathology and applied neurobiology.

[11]  B. Bondy,et al.  3H-spiperone binding to lymphocytes is increased in schizophrenic patients and decreased in parkinson patients , 1989 .

[12]  A. Członkowska,et al.  [3H]Spiperone binding to lymphocyte in extrapyramidal disease and in aging , 1987, Brain, Behavior, and Immunity.

[13]  C. Laterre,et al.  Failure of a peripheral dopaminergic marker in Parkinson's disease. , 1983, Journal of neurology, neurosurgery, and psychiatry.

[14]  J. Maloteaux,et al.  Trapping of labelled ligands in intact cells: a pitfall in binding studies. , 1983, Biochemical pharmacology.

[15]  C. Marsden,et al.  Are dopamine receptors present on human lymphocytes? , 1982, The Journal of pharmacy and pharmacology.

[16]  J. Maloteaux,et al.  Absence of dopamine and muscarinic receptors on human lymphocytes. , 1982, Archives internationales de pharmacodynamie et de therapie.

[17]  M. Baulac,et al.  Decrease in lymphocyte [3H]spiroperidol binding sites in Parkinsonism. , 1980, Life sciences.